UniQure (QURE) Competitor Comparison
We are evaluating the key criteria listed to compare UniQure (QURE) against its competitors in the Biotechnology industry.
Market Capitalization
193 / 368Gross Profits
233 / 278Total Revenue
86 / 300EBITDA
265 / 337Free Cashflow
284 / 352Quick Ratio
81 / 357Earnings per Share
303 / 359Dividend yield
0 / 6Total Cash
43 / 358Performance 3 years
232 / 368Performance 5 years
264 / 368Performance 10 years
130 / 368Linearity 3 years
172 / 368Linearity 5 years
207 / 368Linearity 10 years
26 / 368Total Rank
48 / 368Dividend Rank
35 / 368Valuation Rank
240 / 368Piotroski Rank
316 / 368Muliplier Rank
104 / 368Market Capitalization - QURE ranking 193 / 368
Obligatory risk notice
We would like to point out that the contents of this website are for general information purposes only and do not constitute recommendations for the purchase or sale of specific financial instruments, and therefore do not constitute investment advice. In particular, marketstorylabs.com and its creators cannot assess the extent to which information / recommendations made on the pages correspond to your investment objectives, your risk tolerance and your ability to bear losses. Therefore, if you make any investment decisions based on information on the site, you do so solely on your own responsibility and at your own risk. This in turn means that neither marketstorylabs.com nor its creators are liable for any losses incurred as a result of investment decisions based on the information on the marketstorylabs.com website or other media used.